{
  "claim_id": "claim_002",
  "claim": "Cell- and egg-based flu vaccines have the potential to develop mutations during production, which may reduce their effectiveness.",
  "document": "Liu_et_al.__2024_",
  "verification_stats": {
    "total_extracted": 3,
    "verified": 3,
    "rejected": 0,
    "verification_rate": 1.0
  },
  "verified_evidence": [
    {
      "id": 1,
      "quote": "the manufacturing process can lead to egg adapted mutations in the magglutinin (HA) protein in IIV, that could result in altered an ...iff i (VE) i h i l i",
      "supports_claim": true,
      "explanation": "A very close version of the quote appears in the document, specifically in the first paragraph: 'manufacturing process can lead to egg adapted mutations in themagglutinin (HA) protein in IIV, that could result in altered an ...iff i (VE) i h i l i'. The text is garbled at the end, but the core content about the manufacturing process leading to egg-adapted mutations in the HA protein, which could result in altered vaccine effectiveness (VE), is clearly present.. The quote directly supports the claim. It states that the manufacturing process (specifically for egg-based vaccines) can lead to egg-adapted mutations in the hemagglutinin (HA) protein, and that these mutations could result in altered vaccine effectiveness (VE). This directly substantiates the claim that cell- and egg-based flu vaccines have the potential to develop mutations during production, which may reduce their effectiveness.",
      "presence_explanation": "A very close version of the quote appears in the document, specifically in the first paragraph: 'manufacturing process can lead to egg adapted mutations in themagglutinin (HA) protein in IIV, that could result in altered an ...iff i (VE) i h i l i'. The text is garbled at the end, but the core content about the manufacturing process leading to egg-adapted mutations in the HA protein, which could result in altered vaccine effectiveness (VE), is clearly present.",
      "support_explanation": "The quote directly supports the claim. It states that the manufacturing process (specifically for egg-based vaccines) can lead to egg-adapted mutations in the hemagglutinin (HA) protein, and that these mutations could result in altered vaccine effectiveness (VE). This directly substantiates the claim that cell- and egg-based flu vaccines have the potential to develop mutations during production, which may reduce their effectiveness.",
      "original_relevance": "This quote directly states that the manufacturing process for egg-based vaccines can lead to egg-adapted mutations in the hemagglutinin (HA) protein, which could result in altered vaccine effectiveness (VE), supporting the claim that mutations during production may reduce effectiveness."
    },
    {
      "id": 2,
      "quote": "Repeat vaccination with egg based influenza vaccines could preferentially boost antibodies targeting the egg adapted epi topes and reduce immuno- gen i city to circulating viruses.",
      "supports_claim": true,
      "explanation": "The quote 'Repeat vaccination with egg based influenza vaccines could preferentially boost antibodies targeting the egg adapted epi topes and reduce immuno- gen i city to circulating viruses.' appears almost verbatim on page 1 of the document. The only differences are minor spacing and line breaks, but the core content and meaning are identical.. The quote directly supports the claim. It states that repeat vaccination with egg-based influenza vaccines can preferentially boost antibodies to egg-adapted epitopes (mutations that arise during egg-based production) and reduce immunogenicity to circulating viruses. This means the immune response is focused on the mutated (egg-adapted) version rather than the actual circulating virus, which can reduce vaccine effectiveness. This is a direct mechanistic explanation of how mutations during production may reduce effectiveness, as the claim asserts.",
      "presence_explanation": "The quote 'Repeat vaccination with egg based influenza vaccines could preferentially boost antibodies targeting the egg adapted epi topes and reduce immuno- gen i city to circulating viruses.' appears almost verbatim on page 1 of the document. The only differences are minor spacing and line breaks, but the core content and meaning are identical.",
      "support_explanation": "The quote directly supports the claim. It states that repeat vaccination with egg-based influenza vaccines can preferentially boost antibodies to egg-adapted epitopes (mutations that arise during egg-based production) and reduce immunogenicity to circulating viruses. This means the immune response is focused on the mutated (egg-adapted) version rather than the actual circulating virus, which can reduce vaccine effectiveness. This is a direct mechanistic explanation of how mutations during production may reduce effectiveness, as the claim asserts.",
      "original_relevance": "This quote explains that egg-based vaccines can boost immune responses to egg-adapted epitopes (mutations from production) rather than to the circulating viruses, which can reduce the vaccine's effectiveness."
    },
    {
      "id": 3,
      "quote": "have reported that Q223 R egg adapted change at the HA head domain of A (H1 N1) pdm09 virus can promote virus replication in eggs, alter antigen i city and influence immune response 37 42.",
      "supports_claim": true,
      "explanation": "The quote appears on page 9: 'have reported that Q223 R egg adapted change at the HA head domain of A (H1 N1) pdm09 virus can promote virus replication in eggs, alter antigen i city and influence immune response 37 42.' The wording is nearly identical to the quote to verify, with only minor spacing and formatting differences.. The quote directly supports the claim. It specifically describes an egg-adapted mutation (Q223R) in the HA head domain of A(H1N1)pdm09 that arises during egg-based vaccine production. The quote states that this mutation can promote virus replication in eggs, alter antigenicity, and influence immune response. These changes can potentially reduce vaccine effectiveness, which is the essence of the claim. The quote is a concrete example of how mutations during production (specifically in eggs) can impact vaccine performance.",
      "presence_explanation": "The quote appears on page 9: 'have reported that Q223 R egg adapted change at the HA head domain of A (H1 N1) pdm09 virus can promote virus replication in eggs, alter antigen i city and influence immune response 37 42.' The wording is nearly identical to the quote to verify, with only minor spacing and formatting differences.",
      "support_explanation": "The quote directly supports the claim. It specifically describes an egg-adapted mutation (Q223R) in the HA head domain of A(H1N1)pdm09 that arises during egg-based vaccine production. The quote states that this mutation can promote virus replication in eggs, alter antigenicity, and influence immune response. These changes can potentially reduce vaccine effectiveness, which is the essence of the claim. The quote is a concrete example of how mutations during production (specifically in eggs) can impact vaccine performance.",
      "original_relevance": "This quote provides a specific example of an egg-adapted mutation (Q223R) that occurs during production, which can alter the antigenicity of the virus and influence the immune response, thus potentially reducing vaccine effectiveness."
    }
  ],
  "rejected_evidence": [],
  "model_used": "gpt-4.1"
}